Institute of Medical Biology,Chinese Academy of Medical Sciences
We are professional It is "WHO Collaborative and Research Center on Enteroviruses", as well as master's and doctor's degree conferring unit of the Peking Union Medical College
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
The Representative Research and Production Base for Series of Hepatitis A Vaccines in China
As early as in 1974, IMBCAMS independently established a human diploid cell line, KMB17. Its establishment provides a base for the subsequent development of new vaccines from human diploid cells.
In 1992, the live-attenuated Hepatitis A vaccine (liquid) from IMBCAMS was firstly permitted to market.
The inactivated Hepatitis A vaccine, WEISAIRUIAN®, and the freeze-dried live-attenuated Hepatitis A vaccine, WEISAIRUIJI®, were respectively put into Chinese market in 2003 and 2006.
A Manufacturer Who Remarkably Contributes to Prevent Hepatitis A in China
The Hepatitis A vaccine has been included into the Expanded Program on Immunization (EPI) in 2007.
For more than 20 years, IMBCAMS provided Chinese market about 200 million doses of Hepatitis A vaccines in total.
